Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinomaCredit: Pixabay/CC0 Public DomainInitial results of the NRG Oncology NRG-GI003 c

Updated on: October 19,2026

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinomaCredit: Pixabay/CC0 Public DomainInitial results of the NRG Oncology NRG-GI003 c

Updated on:October 19,2026

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapy

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapyCredit: Thirdman from PexelsThe Journal of Clinical Oncology has published secondary results from the

Updated on: October 21,2026

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapy

Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapyCredit: Thirdman from PexelsThe Journal of Clinical Oncology has published secondary results from the

Updated on:October 21,2026

RNA urine test outperforms standard bladder cancer tests and could help guide treatment

RNA urine test outperforms standard bladder cancer tests and could help guide treatmentCredit: Unsplash/CC0 Public DomainA simple urine test devised by researchers at Stanford Medicine and the VA Palo

Updated on: October 25,2026

RNA urine test outperforms standard bladder cancer tests and could help guide treatment

RNA urine test outperforms standard bladder cancer tests and could help guide treatmentCredit: Unsplash/CC0 Public DomainA simple urine test devised by researchers at Stanford Medicine and the VA Palo

Updated on:October 25,2026

Untangling pancreatic cancer inflammation

Untangling pancreatic cancer inflammationThe prognosis for the most common type of pancreatic cancer, pancreatic ductal adenocarcinoma, also known as PDAC, remains poor. Only around 4% of PDAC patient

Updated on: October 29,2026

Untangling pancreatic cancer inflammation

Untangling pancreatic cancer inflammationThe prognosis for the most common type of pancreatic cancer, pancreatic ductal adenocarcinoma, also known as PDAC, remains poor. Only around 4% of PDAC patient

Updated on:October 29,2026

Gene expression linked to survival differs by kidney cancer subtype

Gene expression linked to survival differs by kidney cancer subtypeCTDNEP1 expression was examined in clear cell and papillary renal cell carcinoma using publicly available cancer databases. Higher CT

Updated on: October 30,2026

Gene expression linked to survival differs by kidney cancer subtype

Gene expression linked to survival differs by kidney cancer subtypeCTDNEP1 expression was examined in clear cell and papillary renal cell carcinoma using publicly available cancer databases. Higher CT

Updated on:October 30,2026